Review : Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs f...

Full description

Saved in:
Bibliographic Details
Published inClinical and molecular hepatology Vol. 21; no. 4; pp. 344 - 348
Main Authors Hyun Young Woo, Jeong Heo
Format Journal Article
LanguageKorean
Published 대한간학회 31.12.2015
Subjects
Drug eluting beads
Hepatocellular carcinoma
Transarterial chemoembolization
Online AccessGet full text

Cover

More Information
Summary:Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE. (Clin Mol Hepatol 2015;21:344-348)
Bibliography:The Korean Association for the Study of the Liver
ISSN:2287-2728
2287-285X